Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Oct 2021, 19:39.
John E. Kao - 13 Oct 2021 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 13 Oct 2021
- Net transaction value
- -$3,706,010
- SEC form
- 4
- Accepted by SEC
- 15 Oct 2021, 19:39:31 UTC
- Prior SEC filing
- 13 May 2021
- Next SEC filing
- 03 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 15 Oct 2021.
Change
- Previous filing in this sequence was filed on 13 May 2021.
- Current net transaction value: -$3,706,010.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock, par value $0.001 per share ("Common Stock")
Sale
- Transaction value
- $2,870,596
- Shares
- -155,641
- Change %
- -3.6%
- Price
- $18.44
- Shares after
- 4,129,396
- Date
- 13 Oct 2021
- Ownership
- See footnote
- Footnotes
- F1, F2, F3
ALHC
transaction
Common Stock
Sale
- Transaction value
- $23,980
- Shares
- -1,262
- Change %
- -0.03%
- Price
- $19.00
- Shares after
- 4,128,134
- Date
- 13 Oct 2021
- Ownership
- See footnote
- Footnotes
- F1, F3, F4
ALHC
transaction
Common Stock
Sale
- Transaction value
- $811,435
- Shares
- -43,097
- Change %
- -1%
- Price
- $18.83
- Shares after
- 4,085,037
- Date
- 14 Oct 2021
- Ownership
- See footnote
- Footnotes
- F1, F3, F5
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 311,030
- Date
- 13 Oct 2021
- Ownership
- Direct
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4. Transactions within a $1.00 price range are reported in accordance with the June 25, 2008 SEC No-Action letter.
Footnote F2
The shares were sold in multiple transactions at prices ranging from $18.00 to $18.97 per share.
Footnote F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Footnote F4
The shares were sold in multiple transactions at prices ranging from $19.00 to $19.025 per share.
Footnote F5
The shares were sold in multiple transactions at prices ranging from $18.23 to $19.05 per share.
Footnote F6
Represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc., that will vest 25% on the first four anniversaries of the initial vesting date.
SEC remarks
Exhibit 24.1 - Power of Attorney